PatientsVille.com LogoPatientsVille.com

Suicide | Veterans Coping Long-term With Active Suicide

Suicide research study

What is the primary objective of this study?

The proposed study seeks to test the efficacy of an intervention to reduce suicide behaviors in Veterans. The Veterans Coping Long Term with Active Suicide Program (CLASP-VA) is an innovative, telephone-based intervention that combines elements of individual therapy, case management, and significant other/family therapy and is designed to be integrated into a VA system.

Who is eligible to participate?

Inclusion Criteria: - suicide attempt or suicidal ideation with any methods, plan, and/or intent to make a suicide attempt within 1 week of hospitalization - age greater than 18 - have a telephone - ability to speak, read, and understand spoken English sufficiently well to complete the procedures of the study Exclusion Criteria: - long-term psychiatric disorder - diagnosis of borderline personality disorder - cognitive impairment which would interfere with adequate participation in the project (MMSE <20)

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Suicide

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Behavioral:Coping Long Term with Active Suicidean intervention to reduce suicide behavior in Veterans recently hospitalized for suicide attempt or ideation with intent.

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

CLASP InterventionA 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.

Safety Assessment and follow up EvaluationTreatment as usual plus enhanced monitoring.

Study Status

Active, not recruiting

Start Date: February 24, 2014

Completed Date: August 31, 2018

Phase: N/A

Type: Interventional

Design:

Primary Outcome: Changes in Columbia Suicide Severity Rating Scale (C-SSRS)

Secondary Outcome: Changes in Beck Hopelessness Scale

Study sponsors, principal investigator, and references

Principal Investigator: Jennifer Marie Primack, PhD MA

Lead Sponsor: VA Office of Research and Development

Collaborator: Butler Hospital

More information:https://clinicaltrials.gov/show/NCT01894841

Discuss Suicide